Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNI | UNP |
|---|---|---|
| Price | $120.95 | $273.70 |
| Change today | ▲ 1.22% | ▼ 0.67% |
| Market cap | $73.06B | $162.60B |
| Return, 3 months | +4.9% | +5.8% |
| Return, year to date | +25.3% | +20.1% |
| Return, 1 year | +36.2% | +21.3% |
| P/E (TTM) | 21.9 | 22.2 |
| P/B | 4.7 | 7.9 |
| P/E percentile vs own 5y | 75th | 86th |
| Dividend yield | 2.10% | 2.02% |
| Revenue growth (YoY, latest qtr) | +11.3% | +11.5% |
| Net profit growth (YoY) | +6.6% | +6.2% |
| Gross margin | 42.0% | 45.6% |
| Operating margin | 37.5% | 40.0% |
| Net margin | 26.9% | 28.8% |
| Return on equity | 22.0% | 39.7% |
| Analyst target vs. price | +17.6% | +22.1% |
| Analyst buy share | 63% | 79% |
| RSI (14) | 45 | 35 |
| 30-day volatility | 18.0% | 20.4% |
| Max drawdown, 1 year | -11.8% | -12.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.